Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4280717 | The American Journal of Surgery | 2009 | 6 Pages |
BackgroundThe role of inducible costimulator (ICOS) in transplantation immunity remains unclear.MethodsA Lewis-to-Brown–Norway (BN) rat liver transplant model was used to explore the effect of ICOS blockade by small interference RNA. Recipient survival rate, number of CD25/ICOS–positive cells, ICOS mRNA and protein levels, and interferon-γ and tumor-necrosis factor-α levels were determined.ResultsRecipient survival was significantly prolonged in rats treated with RNA interference. On day 7 after transplantation, there was a diminished frequency of CD25/ICOS–positive cells and an increased frequency of apoptotic T cells. Furthermore, we found that ICOS blockade could inhibit mRNA and protein expression of ICOS, decrease plasma levels of interferon-γ and tumor-necrosis factor-α, suppress cell infiltration into grafts, and promote tolerance in the interference group.ConclusionsOur data demonstrate that RNA interference is a potent tool to down-modulate ICOS expression and protect allografts from acute rejection.